IL87902A0 - Soluble human cd4 fragments and applications thereof - Google Patents

Soluble human cd4 fragments and applications thereof

Info

Publication number
IL87902A0
IL87902A0 IL87902A IL8790288A IL87902A0 IL 87902 A0 IL87902 A0 IL 87902A0 IL 87902 A IL87902 A IL 87902A IL 8790288 A IL8790288 A IL 8790288A IL 87902 A0 IL87902 A0 IL 87902A0
Authority
IL
Israel
Prior art keywords
fragments
applications
soluble human
soluble
human
Prior art date
Application number
IL87902A
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/217,475 external-priority patent/US5109123A/en
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of IL87902A0 publication Critical patent/IL87902A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
IL87902A 1987-10-08 1988-10-04 Soluble human cd4 fragments and applications thereof IL87902A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10618587A 1987-10-08 1987-10-08
US14431388A 1988-01-14 1988-01-14
US20658588A 1988-06-14 1988-06-14
US07/217,475 US5109123A (en) 1988-06-14 1988-07-11 Alteration of ability of soluble CD4 fragments to bind HIV

Publications (1)

Publication Number Publication Date
IL87902A0 true IL87902A0 (en) 1989-03-31

Family

ID=27493499

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87902A IL87902A0 (en) 1987-10-08 1988-10-04 Soluble human cd4 fragments and applications thereof

Country Status (9)

Country Link
EP (1) EP0400010A1 (en)
JP (1) JPH03504234A (en)
AU (1) AU2614888A (en)
DK (1) DK87490A (en)
ES (1) ES2012129A6 (en)
GR (1) GR1000850B (en)
IL (1) IL87902A0 (en)
NZ (1) NZ226475A (en)
WO (1) WO1989003222A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
ZA887365B (en) * 1987-10-02 1990-05-30 Genentech Inc Adheson variants
US5206353A (en) * 1988-07-23 1993-04-27 The United States Of America As Represented By The Department Of Health And Human Services CD-4/cytotoxic gene fusions
AU623924B2 (en) * 1988-07-22 1992-05-28 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cytotoxic agent against specific virus infection
EP0408372A1 (en) * 1989-07-13 1991-01-16 Smithkline Beecham Corporation Anti-viral therapy
KR927003613A (en) * 1989-08-23 1992-12-18 더 제너랄 호스피탈 코오퍼레이숀 CD4 polypeptides, glycosylated human CD4 molecules, fragments thereof, fusion proteins, gene sequences, and uses thereof of non-human primates
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation
JPH0725794B2 (en) * 1990-03-23 1995-03-22 呉羽化学工業株式会社 Novel peptide
DE69133181T2 (en) * 1990-09-14 2003-04-30 Colorado State University, Fort Collins DESIGN OF BIOACTIVE PEPTIDES BASED ON IMMUNGLOBULIN STRUCTURES
AU1438592A (en) * 1991-02-08 1992-09-07 Progenics Pharmaceuticals, Inc. Cd4-gamma1 and cd4-igg1 chimeras
ATE288923T1 (en) 1991-02-08 2005-02-15 Progenics Pharm Inc CD4-GAMMA2 AND CD4-IGG2 CHIMERAS
US7070991B2 (en) 1991-02-08 2006-07-04 Progenics Pharmaceuticals, Inc. Cells expressing a CD4-IgG2 chimeric heterotetramer
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
EP0510483A1 (en) * 1991-04-22 1992-10-28 Boehringer Ingelheim Pharmaceuticals Inc. Method for the detection of viruses
WO2000039303A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Modified hiv env polypeptides
JP2003523721A (en) 1998-12-31 2003-08-12 カイロン コーポレイション Polynucleotides encoding antigenic HIVC-type polypeptides, polypeptides, and uses thereof
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1427806A4 (en) 2001-08-31 2006-04-26 Chiron Corp Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CN105209057B (en) 2013-03-15 2020-03-27 美国卫生和人力服务部 Stable human single CD4 domain and fusion protein
WO2017055522A1 (en) 2015-09-29 2017-04-06 Academisch Medisch Centrum Stabilized env proteins of hiv

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751751T2 (en) * 1986-08-21 1996-10-17 Univ Columbia DNA ENCODING THE T CELL SURFACE PROTEIN T4 AND USE OF T4 FRAGMENTS IN THE TREATMENT OF AIDS
NZ226414A (en) * 1987-10-02 1992-07-28 Genentech Inc Cd4 peptide adhesion variants and their preparation and use

Also Published As

Publication number Publication date
DK87490D0 (en) 1990-04-06
EP0400010A1 (en) 1990-12-05
ES2012129A6 (en) 1990-03-01
JPH03504234A (en) 1991-09-19
WO1989003222A1 (en) 1989-04-20
NZ226475A (en) 1991-03-26
AU2614888A (en) 1989-05-02
DK87490A (en) 1990-06-08
GR1000850B (en) 1993-02-17

Similar Documents

Publication Publication Date Title
IL87902A0 (en) Soluble human cd4 fragments and applications thereof
IL82383A0 (en) Pyridyl imidates and their use as fungicides
AR243910A1 (en) Polymer particles and their preparation
EP0269393A3 (en) Absorbent products and their manufacture
EP0268498A3 (en) Absorbent products and their manufacture
IL88814A0 (en) Soluble polyimidesiloxanes,their preparation and use
NZ224046A (en) Hiv antigenic peptide fragments and their use
IL95824A0 (en) Peptides associated with cd4 binding region of gp120 and their use
AU2146388A (en) Orthotic pads and methods
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
JPS6454032A (en) Polydisilacyclobutasilazane and its preparation and use
GB2186291B (en) Alloy and product made therefrom
AU8316587A (en) Pharmaceutical compositions and their use
EP0435199A3 (en) Acrylic gel material and acrylic gel preparation
AU7580187A (en) Androstane-type and cortical aminoesters
ZA882353B (en) Human tumour-associated antigen
EP0255801A3 (en) Anilinotriazines and their use
GB2197197B (en) Soluble and/or splitable tablets
ZW988A1 (en) Improved polymeric film-enveloped explosive catridges and their manufacture and use
NZ227594A (en) Human interleukin-1alpha and preparations thereof
PH24632A (en) Tin diiododeuteroporphyrin and therapeutic use thereof
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
IL87779A0 (en) 4-azasaccharines,4-aza-dihydro-and-tetrahydro-saccharines and their preparation
ZA882852B (en) Pyrrolealdehydes,their preparation and their use